ACM
ELV icon

Alamar Capital Management’s Elevance Health ELV Stock Holding History

Alamar Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,368
Closed -$741K – 83
2024
Q2 		$741K Buy
+1,368
New +$723K 0.45% 53
2023
Q3 		– Sell
-6,101
Closed -$2.71M – 63
2023
Q2 		$2.71M Buy
6,101
+445
+8% +$205K 1.99% 22
2023
Q1 		$2.6M Buy
5,656
+14
+0.2% +$6.66K 2.16% 15
2022
Q4 		$2.89M Sell
5,642
-76
-1% -$38.6K 2.97% 7
2022
Q3 		$2.6M Sell
5,718
-626
-10% -$300K 2.92% 9
2022
Q2 		$3.06M Sell
6,344
-1,197
-16% -$592K 3.45% 7
2022
Q1 		$3.7M Sell
7,541
-2,329
-24% -$1.06M 3.11% 7
2021
Q4 		$4.58M Buy
9,870
+581
+6% +$244K 3.29% 6
2021
Q3 		$3.46M Buy
9,289
+847
+10% +$322K 2.68% 11
2021
Q2 		$3.22M Buy
8,442
+74
+0.9% +$28.3K 2.81% 14
2021
Q1 		$3M Buy
8,368
+897
+12% +$288K 2.89% 9
2020
Q4 		$2.4M Buy
+7,471
New +$2.29M 2.59% 16

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alamar Capital Management's ELV Position: Q3 2024 in Review

Alamar Capital Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 1,368 shares — an estimated $741K sold.

Alamar Capital Management first reported a position in ELV in Q4 2020 and held it in 12 quarters. The position peaked at $4.58M in Q4 2021. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Alamar Capital Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Alamar Capital Management sold 1,368 Elevance Health shares in Q3 2024, an estimated $741K.
  • Alamar Capital Management first reported a position in Elevance Health in Q4 2020 and held it in 12 quarters.
  • Alamar Capital Management's Elevance Health position peaked at $4.58M in Q4 2021.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Alamar Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.